Percutaneous transluminal myocardial revascularisation: current status and future perspectives.
J Indian Med Assoc
;
2000 Nov; 98(11): 715-8
Article
in English
| IMSEAR
| ID: sea-104265
ABSTRACT
Percutaneous transluminal myocardial revascularisation presently appears to be a potential palliative treatment for coronary artery disease, neither controlled with drugs nor amenable to available coronary revascularisation techniques. Ongoing trials will provide answer to short and long term efficacy. Recent developments using angiogenic growth factors appear very promising, and the role of growth factors as an adjunct to percutaneous transmyocardial revascularisation with laser remains to be seen.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Palliative Care
/
Humans
/
Angioplasty, Balloon, Coronary
/
Angioplasty, Balloon, Laser-Assisted
/
Coronary Disease
Type of study:
Controlled clinical trial
Language:
English
Journal:
J Indian Med Assoc
Year:
2000
Type:
Article
Similar
MEDLINE
...
LILACS
LIS